Head-to-Head

Halozyme Therapeutics, Inc. vs. Surrozen, Inc. Common

HALO

Halozyme Therapeutics, Inc.

$93.09 +0.06%

VS SRZN

Surrozen, Inc. Common

$29.50 -3.81%

Halozyme Therapeutics, Inc. and Surrozen, Inc. Common are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

HALOSRZN
Market Cap $10.61 billion $584.62 million

HALO leads on 1 of 1 size & scale factors.

Risk & Sentiment

HALOSRZN
Short Interest 9.75% 0.20%

SRZN leads on 1 of 1 risk & sentiment factors.

Dig deeper: HALO overview, HALO financials, SRZN overview, SRZN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.